Trial intelligence / Profile preview

Pre-transplant Rapamycin in Islet Transplantation

NCT01060605Phase 3Completed

Sponsor
IRCCS Ospedale San Raffaele
Start
Oct 2001
Primary completion
Dec 2005
Modality
Nanoparticles, Small Molecules
Countries
1
01

Overview

A Phase 3 trial of nab-sirolimus in type 1 diabetes mellitus (T1D), sponsored by IRCCS Ospedale San Raffaele. Started Oct 2001; status: completed.

02

Drugs

nab-sirolimus
03

Conditions

type 1 diabetes mellitus (T1D)

Beyond the preview

Go deeper on NCT01060605.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01060605.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call